Dawn was a participant in the HERA clinical trial after being diagnosed with HER2-positive breast cancer.

It's because of trial participants like Dawn, that women like Nic were given a renewed chance at life. In this podcast, Dawn and Nic reflect on their experiences and how they have benefited from clinical trials research.